Study guide

2.1 Osteoarthritis Pathophysiology, Risk Factors & Clinical Phenotypes

ONCB Orthopaedic Nurse Certified ONC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: ONC Exam Overview, Core Nursing Foundations & Neurovascular Assessment

1.1 ONC Certification Framework, Exam Blueprint & Test Strategies 1.2 Comprehensive Musculoskeletal Assessment & Diagnostic Modalities 1.3 Neurovascular Assessment & Orthopaedic Physical Examination Techniques

2 Chapter 2: Degenerative Joint Disease & Osteoarthritis Management

2.1 Osteoarthritis Pathophysiology, Risk Factors & Clinical Phenotypes 2.2 Conservative Management, Non-Pharmacologic & Pharmacologic Therapies for OA 2.3 Intra-Articular Injections & Joint Preservation Interventions

3 Chapter 3: Total Joint Arthroplasty — Hip & Knee

3.1 Total Hip Arthroplasty (THA): Surgical Approaches, Biomechanics & Component Types 3.2 Total Hip Arthroplasty: Postoperative Management, Hip Precautions & Dislocation Prevention 3.3 Total Knee Arthroplasty (TKA): Indications, Implant Designs & Surgical Techniques 3.4 Total Knee Arthroplasty: Postoperative Nursing Care, Pain Management & Early Mobilization

4 Chapter 4: Shoulder & Upper/Lower Extremity Arthroplasty and Revision Surgery

4.1 Total Shoulder Arthroplasty (TSA): Anatomic vs. Reverse TSA Indications & Precautions 4.2 Ankle, Elbow & Wrist Arthroplasty: Indications, Nursing Management & Functional Outcomes 4.3 Revision Arthroplasty, Aseptic Loosening, Osteolysis & Implant Failure

5 Chapter 5: Spinal Degenerative Disorders & Spinal Surgery

5.1 Cervical & Lumbar Spondylosis, Degenerative Disc Disease & Herniation 5.2 Spinal Stenosis, Neurogenic Claudication & Spondylolisthesis 5.3 Surgical Interventions: ACDF, Posterior Cervical Decompression, Lumbar Laminectomy & Fusion 5.4 Postoperative Spinal Nursing Care, CSF Leak Detection & Log-Rolling Protocols

6 Chapter 6: Orthopaedic Trauma: Fracture Mechanics, Classification & Healing

6.1 Fracture Mechanics, Morphology & AO/OTA Classification Principles 6.2 Open Fracture Management & Gustilo-Anderson Classification Protocol 6.3 Biology of Bone Healing, Physis (Salter-Harris) Injuries & Healing Complications

7 Chapter 7: Orthopaedic Emergencies & Trauma Complications

7.1 Acute Compartment Syndrome: Pathophysiology, The 6 Ps, Pressure Monitoring & Fasciotomy 7.2 Fat Embolism Syndrome (FES): Pathophysiology, Triad Recognition & Supportive Care 7.3 Hemorrhagic Shock, Pelvic Ring Disruptions & Damage Control Orthopaedics 7.4 Traumatic Spinal Cord Injury (SCI), Spinal/Neurogenic Shock & Autonomic Dysreflexia

8 Chapter 8: Upper Extremity, Lower Extremity & Pelvic Trauma Nursing Care

8.1 Proximal Femur & Hip Fractures: Femoral Neck, Intertrochanteric & Subtrochanteric Fixation 8.2 Diaphyseal & Articular Fractures of the Lower Extremity (Femur, Tibia, Ankle & Foot) 8.3 Upper Extremity Fractures, Dislocation Management & Peripheral Nerve Injuries

9 Chapter 9: Casts, Splints, Traction & External Fixation

9.1 Plaster & Synthetic Casting: Application, Cast Care, Windowing & Bivalving 9.2 Skin & Skeletal Traction: Buck's, Russell's, Balanced Suspension & Skeletal Traction Protocols 9.3 External Fixation, Ring Fixators, Pin Site Care Protocols & Infection Surveillance

10 Chapter 10: Sports Injuries: Ligamentous, Meniscal & Soft-Tissue Pathologies

10.1 Knee Ligamentous Injuries: ACL, PCL, MCL & LCL Pathophysiology, Special Tests & Reconstruction 10.2 Meniscal Pathologies: Vascular Zones, Tear Patterns, Meniscectomy vs. Meniscal Repair 10.3 Shoulder Instability, Labral Lesions (SLAP/Bankart) & Rotator Cuff Disorders 10.4 Tendinopathies, Overuse Syndromes, Concussion Protocol & Return-to-Play Criteria

11 Chapter 11: Metabolic Bone Disorders & Fragility Fractures

11.1 Osteoporosis & Osteopenia: Bone Remodeling, Risk Factors & DEXA Diagnostics 11.2 Pharmacotherapy: Bisphosphonates, Denosumab, Anabolic Agents & Patient Education 11.3 Osteomalacia, Rickets & Paget's Disease of Bone (Osteitis Deformans) 11.4 Vertebral Compression Fractures: Pathogenesis, Bracing, Vertebroplasty & Kyphoplasty

12 Chapter 12: Inflammatory Musculoskeletal Disorders & Infectious Conditions

12.1 Rheumatoid Arthritis: Autoimmune Pathophysiology, Manifestations & DMARD / Biologic Therapies 12.2 Ankylosing Spondylitis, Psoriatic Arthritis, Gout & Pseudogout (CPPD) 12.3 Septic Arthritis: Microorganisms, Arthrocentesis Findings, Emergency Debridement & Nursing Care 12.4 Osteomyelitis: Acute vs. Chronic, Biofilm Dynamics, Surgical Debridement & Long-Term Antibiotic Care

13 Chapter 13: Congenital, Pediatric & Musculoskeletal Oncologic Conditions

13.1 Developmental Dysplasia of the Hip (DDH), Clubfoot (Talipes Equinovarus) & Pediatric Hip Disorders 13.2 Pediatric & Adolescent Spinal Deformities: Idiopathic Scoliosis, Kyphosis & Bracing / Surgery 13.3 Musculoskeletal Oncology: Benign Bone Tumors, Primary Malignancies & Metastatic Bone Disease

14 Chapter 14: Neuromuscular Syndromes, Pain Modalities & Rehabilitation Competencies

14.1 Peripheral Nerve Compression Neuropathies (CTS, Cubital Tunnel, Tarsal Tunnel) & Complex Regional Pain Syndrome 14.2 Multimodal Pharmacologic Analgesia, Regional Nerve Blocks, PCA Management & Opioid Stewardship 14.3 Progressive Ambulation, Assistive Device Prescriptions, Crutch Gaits, DVT Prophylaxis & Discharge Planning

2.1 Osteoarthritis Pathophysiology, Risk Factors & Clinical Phenotypes

Key Takeaways Explain This Topic AI

Osteoarthritis (OA) is a progressive, whole-organ joint disease characterized by chondrocyte metabolic dysregulation, upregulation of matrix metalloproteinase-13 (MMP-13) and aggrecanases (ADAMTS-4/5), articular cartilage fibrillation, and low-grade chronic synovitis.

Subchondral bone undergoes profound structural remodeling during disease progression, transitioning from microfractures and vascular invasion to marked subchondral sclerosis, eburnation (polished ivory-like bone), and fluid-filled subchondral cysts (geodes).

Etiologic drivers integrate systemic susceptibility (aging, female sex post-menopause, genetic polymorphisms, metabolic syndrome with pro-inflammatory adipokines) with localized mechanical stresses (obesity, joint malalignment, prior intra-articular ligamentous or meniscal trauma).

The Kellgren-Lawrence (KL) grading system standardizes radiographic severity from Grade 0 (no pathology) to Grade 4 (severe joint space narrowing, massive osteophytes, severe subchondral sclerosis, and marked bony contour deformity).

Primary nodal osteoarthritis exhibits distinct clinical phenotypes, notably Heberden nodes at the distal interphalangeal (DIP) joints and Bouchard nodes at the proximal interphalangeal (PIP) joints, distinguishing it from autoimmune inflammatory arthritides.

Last updated: August 2026

2.1 Osteoarthritis Pathophysiology, Risk Factors & Clinical Phenotypes

Core Clinical Principle: Osteoarthritis (OA) is no longer conceptualized as simple mechanical "wear and tear" of articular cartilage. Contemporary orthopaedic science defines OA as a multifactorial, progressive failure of the whole joint as an organ , involving articular cartilage breakdown, chondrocyte apoptosis, subchondral bone remodeling, osteophyte formation, ligamentous laxity, meniscal degeneration, and low-grade immune-mediated synovial inflammation.

Pathophysiology of Articular Cartilage Degradation

Healthy articular (hyaline) cartilage is an avascular, aneural, and alymphatic specialized connective tissue. Its extracellular matrix (ECM) is composed predominantly of Type II collagen fibrils (providing tensile strength), aggrecan proteoglycans bound to hyaluronic acid (providing compressive stiffness and osmotic hydration), and water (comprising 65% to 80% of total wet weight). Chondrocytes represent the sole resident cell type, responsible for maintaining ECM homeostasis. Normal Cartilage Homeostasis: Anabolic Synthesis (Type II Collagen + Aggrecan) = Catabolic Turnover

↓ [Biomechanical Overload + Inflammatory Cascades]

OA Pathophysiologic State: Catabolic Breakdown (MMP-13 + ADAMTS-4/5) >> Anabolic Repair → Chondrocyte Apoptosis

Molecular & Enzymatic Cascades

In osteoarthritis, abnormal biomechanical loading and biochemical triggers initiate a destructive cascade:

Chondrocyte Activation & Phenotypic Shift: Quiescent chondrocytes transition to a hypertrophic, catabolic phenotype. They release pro-inflammatory cytokines, primarily interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) , which bind to chondrocyte surface receptors in an autocrine and paracrine loop.

Upregulation of Matrix-Degrading Proteases:

Matrix Metalloproteinases (MMPs): Specifically MMP-13 (collagenase-3) , along with MMP-1 and MMP-8, cleaves the triple helix of Type II collagen, causing irreversible structural disruption of the cartilage framework.

Aggrecanases (ADAMTS-4 and ADAMTS-5): A Disintegrin and Metalloproteinase with Thrombospondin Motifs enzymes cleave aggrecan at specific glutamate-alanine peptide bonds, causing loss of proteoglycan aggregates, decreased glycosaminoglycan (GAG) content, and loss of compressive water-binding capacity.

Cartilage Fibrillation & Fissuring: The superficial zone of cartilage develops microscopic disruptions (fibrillation), progressing to deep vertical clefts (fissuring) that extend through the transitional and radial zones toward the subchondral bone.

Chondrocyte Cloning & Apoptosis: Chondrocytes initially undergo abortive proliferative clustering ("cloning" or chondrone formation) in an attempt to repair matrix loss, followed by accelerated chondrocyte senescence and programmed cell death (apoptosis).

Tidemark Duplication & Cartilage Thinning: The calcified cartilage zone advances into the uncalcified hyaline cartilage, marked by duplication of the histological "tidemark" and progressive full-thickness articular cartilage loss.

Subchondral Bone Dynamics: Sclerosis, Eburnation, Cysts & Osteophytes

Articular cartilage and subchondral bone function as an integrated functional osteochondral unit. Cartilage loss alters load distribution across the subchondral plate, initiating dramatic structural bone remodeling:

Pathologic Feature Pathophysiologic Mechanism Radiographic & Clinical Significance

Subchondral Sclerosis Increased focal biomechanical stress causes trabecular microfractures, accelerated osteoblast activity, and deposition of thickened, hyperdense, poorly mineralized woven bone. Appears as dense, radio-opaque whiteness underlying the joint line on plain radiographs; reduces shock-absorbing capacity of the bone bed.

Eburnation Complete denudation of overlying hyaline cartilage exposes bare subchondral bone to direct friction against the opposing articular surface, creating a polished, ivory-like bone surface. Represents end-stage full-thickness cartilage loss; source of intense mechanical pain and severe crepitus.

Subchondral Cysts (Geodes) Elevated intra-articular hydrostatic pressure forces synovial fluid through microcracks in exposed subchondral bone, accompanied by focal osteoclastic bone resorption and fibrous tissue encasement. Well-circumscribed radiolucent (dark) lucencies with sclerotic margins in the subchondral bone; predisposing to micro-collapse.

Osteophytosis (Bone Spurs) Mechanical stress and growth factors ( TGF-β and Bone Morphogenetic Proteins [BMPs] ) stimulate periosteal mesenchymal stem cells and synoviocytes at joint margins, driving endochondral ossification. Protruding marginal bony outgrowths that widen the joint surface area to distribute load, but cause mechanical impingement, capsular stretch, and restricted range of motion.

Etiology & Risk Factor Stratification

Osteoarthritis is classified into Primary (Idiopathic) OA , which arises without an identifiable antecedent trigger, and Secondary OA , which develops secondary to known intra-articular trauma, infection, metabolic disease, or structural congenital deformity. Primary Drivers of Osteoarthritis Development

  • ├── Biomechanical Stresses
  • │ ├── Joint Malalignment (Genu Varum → Medial Knee OA; Genu Valgum → Lateral Knee OA)
  • │ ├── Post-Traumatic Intra-Articular Disruptions (ACL Tears, Meniscal Tears / Meniscectomy)
  • │ └── Repetitive Occupational Joint Overload (Heavy Lifting, Frequent Knee Bending)
  • └── Systemic & Metabolic Factors
  • ├── Advanced Age (Cellular Senescence, Advanced Glycation End-products [AGEs])
  • ├── Female Sex & Hormonal Changes (Postmenopausal Estrogen Decline)
  • ├── Genetic Polymorphisms (GDF5, SMAD3, COL2A1 Gene Loci)
  • └── Obesity & Adipokines (Compressive Load + Systemic Low-Grade Inflammation via Leptin & Resistin)
  • The Dual Biomechanical-Metabolic Impact of Obesity

Obesity influences osteoarthritis through two distinct, synergistic mechanisms:

Mechanical Overload: Every 1 pound of body weight transmits approximately 4 pounds of compressive force across the tibiofemoral joint during level ambulation, and up to 7 to 8 pounds during stair climbing.

Metabolic/Endocrine Signaling: Adipose tissue is an active endocrine organ secreting pro-inflammatory adipokines, including leptin , resistin , and visfatin , while suppressing anti-inflammatory adiponectin . Leptin crosses the blood-synovial barrier and stimulates chondrocytes and synovial fibroblasts to upregulate MMP-1, MMP-3, and MMP-13 expression. This explains the elevated prevalence of non-weight-bearing hand OA in obese individuals.

Kellgren-Lawrence (KL) Radiographic Grading System

The Kellgren-Lawrence system is the universal gold standard for classifying the radiographic severity of osteoarthritis on weight-bearing plain radiographs:

KL Grade Classification Radiographic Features Clinical Correlation

Grade 0 None No radiographic features of osteoarthritis; normal joint architecture. Asymptomatic; fully preserved joint function.

Grade 1 Doubtful Doubtful joint space narrowing (JSN); possible minute osteophytic lipping. Minimal or absent joint symptoms; occasional stiffness.

Grade 2 Minimal / Mild Definite osteophytes present; possible or mild joint space narrowing. Mild joint aching with activity; morning stiffness lasting <30 minutes.

Grade 3 Moderate Moderate multiple osteophytes; definite joint space narrowing; some subchondral sclerosis; possible bone contour deformity. Moderate-to-severe pain, joint crepitus, reduced range of motion, mechanical catching.

Grade 4 Severe Large, mature osteophytes; marked/complete joint space narrowing (bone-on-bone contact); severe subchondral sclerosis; definite deformity of bone contours. Severe constant pain (including rest and night pain), fixed deformity (varus/valgus), profound functional disability.

Clinical Manifestations & Nodal Hand Phenotypes

Clinical diagnosis of osteoarthritis integrates patient history, physical examination, and radiographic verification:

Joint Pain: Typically insidious, aching, and mechanical—exacerbated by weight-bearing or joint use, and alleviated by rest. In advanced stages, pain occurs at rest and disrupts sleep.

Morning Stiffness ("Gel Phenomenon"): Brief, transient stiffness following periods of inactivity, characteristically lasting less than 30 minutes (differentiating OA from rheumatoid arthritis, where morning stiffness typically exceeds 60 minutes).

Crepitus & Decreased Range of Motion: Coarse, palpable grinding sensations during joint excursion due to irregular, roughened cartilaginous and bony contact surfaces.

Joint Effusions: Mild, cool effusions resulting from low-grade synovial inflammation. Synovial fluid analysis reveals non-inflammatory fluid (clear/straw-colored, high viscosity, WBC count <2,000 cells/mcL, <25% polymorphonuclear leukocytes). Hand Osteoarthritis Nodal Distribution:

  • [DIP Joint] ─── Heberden Nodes (Distal Interphalangeal)
  • │
  • [PIP Joint] ─── Bouchard Nodes (Proximal Interphalangeal)
  • │
  • [MCP Joint] ─── Spared in Primary OA (Characteristic of RA)
  • │
  • [1st CMC Joint] ─ "Squaring" of the Thumb Base / First Metacarpal Joint
  • Heberden Nodes vs. Bouchard Nodes

Heberden Nodes: Posterolateral bony and cartilaginous enlargements located at the distal interphalangeal (DIP) joints of the fingers. Associated with primary nodal generalized OA, strong familial predisposition, and female predominance.

Bouchard Nodes: Hard, bony outgrowths located at the proximal interphalangeal (PIP) joints of the hands. Less common than Heberden nodes but signify widespread interphalangeal disease.

First Carpometacarpal (CMC) Involvement: Degeneration at the trapeziometacarpal joint of the thumb base causes localized subluxation, tenderness, and a classic "squared" appearance of the hand, with positive grind test during axial compression and rotation.

Loading diagram... Pathophysiologic Cascade of Osteoarthritis